Vita Life Sciences Limited (ASX:VLS)
Australia · Delayed Price · Currency is AUD 2.520
-0.080 (-3.08%)
At close: Mar 4, 2026
Vita Life Sciences Market Cap
Vita Life Sciences has a market cap or net worth of 144.02 million as of March 4, 2026. Its market cap has increased by 39.87% in one year.
Market Cap
144.02M
Enterprise Value
110.76M
Revenue
93.27M
Ranking
n/a
PE Ratio
14.17
Stock Price
2.52
Market Cap Chart
Since August 23, 2007, Vita Life Sciences's market cap has increased from 2.18M to 144.02M, an increase of 6,498.36%. That is a compound annual growth rate of 25.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 144.02M | 2.20% |
| Dec 31, 2025 | 140.92M | 26.53% |
| Dec 31, 2024 | 111.37M | 16.19% |
| Dec 27, 2023 | 95.85M | 25.15% |
| Dec 21, 2022 | 76.59M | -26.95% |
| Dec 31, 2021 | 104.86M | 93.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Syntara | 50.66M |
| Medical Developments International | 50.13M |
| Little Green Pharma | 32.11M |
| Vitura Health | 28.50M |
| IDT Australia | 21.37M |
| Peak Processing | 20.86M |
| Cann Group | 12.71M |
| Epsilon Healthcare | 10.12M |